SuperSonic Imagine

SuperSonic Imagine

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $28M

Overview

SuperSonic Imagine is a pioneer in ultrasound imaging, known for its proprietary ShearWave Elastography technology, which provides quantitative tissue stiffness measurements in real-time. The company targets the global diagnostic imaging market with systems used in radiology, obstetrics/gynecology, and other clinical specialties. As a historically public company that faced financial challenges, it was acquired by Hologic, Inc. in 2021, integrating its technology into a larger portfolio. Its core value proposition lies in enhancing diagnostic capabilities beyond conventional anatomical ultrasound.

OncologyWomen's HealthHepatologyMusculoskeletal

Technology Platform

UltraFast ultrasound imaging platform enabling real-time, quantitative ShearWave Elastography to map tissue stiffness.

Funding History

2
Total raised:$28M
Series B$20M
Series A$8M

Opportunities

Leveraging Hologic's global sales force and strong presence in breast health to drive adoption of elastography-enhanced ultrasound systems.
Expanding into high-growth applications like non-alcoholic fatty liver disease (NAFLD) diagnosis and point-of-care musculoskeletal imaging.
Integrating AI tools to enhance workflow and diagnostic reproducibility, creating a next-generation smart ultrasound platform.

Risk Factors

Facing intense competition from large, established imaging conglomerates with broad portfolios and significant R&D budgets.
Navigating reimbursement challenges for new ultrasound applications, which can slow clinical adoption.
Potential for technology disruption from AI-enhanced conventional ultrasound or other imaging modalities that may reduce the need for dedicated elastography systems.

Competitive Landscape

Operates in the highly competitive diagnostic ultrasound market dominated by GE Healthcare, Philips, Siemens Healthineers, and Canon Medical, all of whom have developed their own elastography technologies. Competes with other specialized elastography devices, such as FibroScan for liver assessment. Differentiation relies on the quantitative accuracy, real-time capability, and large-field-of-view of its proprietary ShearWave technology.